Canaccord Genuity Reiterates Buy Rating on Doximity, Inc. (DOCS)

Market Context

Doximity, Inc. operates in the Healthcare sector. The stock currently trades at $32.51 with a market capitalization of $8.3B. The stock has declined 44.6% over the past 52 weeks.

Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Doximity, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Doximity, Inc.

Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Nov 06, 2026	RBC Capital	Outperform	N/A
Nov 06, 2026	Canaccord Genuity	Buy	N/A
Nov 06, 2026	Evercore ISI Group	In-Line	N/A
Nov 06, 2026	Needham	Buy	N/A
Sep 29, 2026	Evercore ISI Group	In-Line	N/A

Related Tools: Analyst Ratings Dashboard | View DOCS Stock Page